Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

NCT04928222 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

COMBINATION_PRODUCT: Doxorubicin-containing MNA
DRUG: Placebo-containing MNA

Sponsor

SkinJect, Inc.